SCHEMBL32659670

SCHEMBL32659670

CC(c1c(O)c2ccccc2oc1=O)c1c(O)c2ccccc2oc1=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
VKORC1 Q9BQB6 2/20 0.82
NQO1 P15559 7/20 0.69
TOP1 P11387 1/20 0.69
CYP2C9 P11712 6/20 0.68
CRHBP P24387 1/20 0.68
CASP7 P55210 1/20 0.68
CASP6 P55212 1/20 0.68
CRHR2 Q13324 1/20 0.68
HIF1A Q16665 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL310481 1.00 VKORC1 (0.82) VKORC1NQO1TOP1CYP2C9CRHBP
SCHEMBL7349603 0.91 VKORC1 (1.00) VKORC1NQO1TOP1CYP2C9CRHBP
SCHEMBL14078661 0.90 NQO1 (0.73) VKORC1NQO1TOP1CYP2C9CRHBP
SCHEMBL18126686 0.86 NQO1 (0.78) VKORC1NQO1TOP1CYP2C9CRHBP
SCHEMBL14172134 0.85 NQO1 (0.68) VKORC1NQO1TOP1CYP2C9CRHBP
SCHEMBL8868322 0.84 VKORC1 (0.69) VKORC1NQO1CYP2C9
SCHEMBL8469143 0.84 VKORC1 (0.78) VKORC1NQO1TOP1CYP2C9CRHBP
SCHEMBL14078663 0.84 CYP2C9 (0.72) VKORC1NQO1TOP1CYP2C9CRHBP
SCHEMBL28761758 0.84 VKORC1 (0.69) VKORC1NQO1TOP1CYP2C9CRHBP
SCHEMBL8042698 0.83 CYP2C9 (0.86) VKORC1NQO1TOP1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-121313634-B Application of biscoumarin derivative in preparation of aquatic animal Seriola nocardia control medicine 西北农林科技大学深圳研究院 2026-02-13 CN disclosed
CN-121313634-A Application of biscoumarin derivative in preparation of aquatic animal Seriola nocardia control medicine 西北农林科技大学深圳研究院 2026-01-13 CN disclosed